Cas:864754-25-6 N-(pyridin-4-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide manufacturer & supplier

We serve Chemical Name:N-(pyridin-4-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide CAS:864754-25-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(pyridin-4-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Chemical Name:N-(pyridin-4-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
CAS.NO:864754-25-6
Synonyms:N-PYRIDIN-4-YLMETHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE;Benzamide,N-(4-pyridinylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)
Molecular Formula:C19H23BN2O3
Molecular Weight:338.20900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:60.45000
Exact Mass:338.18000
LogP:2.70170

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-PYRIDIN-4-YLMETHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzamide,N-(4-pyridinylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-PYRIDIN-4-YLMETHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE Use and application,Benzamide,N-(4-pyridinylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) technical grade,usp/ep/jp grade.


Related News: EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML). acetic acid,1-(2-ethenoxyethoxy)ethanol manufacturers Orchard’s decision is suggestive of the difficulty drugmakers can face in turning complex, but promising rare disease treatments into a sustainable business. The termination wasn’t unexpected; Orchard said last May it was reducing staff and reordering its priorities, reducing investment in OTL-101 as a result. 1,2,3-Oxathiazin-4(3H)-one, 6-ethyl-, 2,2-dioxide suppliers Setting up of these plants will make the country self-reliant to a large extent in respect of these bulk drugs, it noted. diammine([13,17-bis(2-carboxylatoethyl)-3,8-diiodo-2,7,12,18-tetramethyl]porphinatozinc(II)-O,O’)platinum(II) vendor & factory.